Vitamin B2: benefits, dosage, contraindications

Mis à jour le

Riboflavin is an essential vitamin used in the production of the two flavocoenzymes, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These cofactors attach to proteins called flavoproteins. This activates flavoproteins, which play a role in many enzymatic and metabolic processes in the body. Small amounts of riboflavin are present in most animal and plant tissues. Riboflavin is found in many foods, including milk, meat, eggs, nuts, cereal germ, and green vegetables. The early symptoms of riboflavin deficiency are often non-specific and include weakness, fatigue, oral pain, and stomatitis. Clinical symptoms of deficiency appear after 3-4 months of insufficient intake. The manifestations of deficiency initially occur in tissues with high and rapid cell turnover, such as epithelial tissue and skin: - Stomatitis, cold sores - Inflammation of the tongue - A red or bleeding mouth or oral cavity (hyperemia) and swollen (edema). - Eye and visual disorders, with symptoms such as burning, itching, light sensitivity, and conjunctivitis. - Inflammatory skin conditions, seborrheic dermatitis - Hair loss - Poor wound healing - Anemia Vitamin B2 contributes to normal energy metabolism, to the normal functioning of the nervous system, to the maintenance of normal skin and mucous membranes, to normal vision, to the maintenance of normal red blood cells, to normal iron metabolism, to the reduction of fatigue and to the protection of cells from free radicals (antioxidant effect).

Other name(s) 

Riboflavin

Scientific name(s)

Riboflavin

Family or group: 

Vitamins


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Vitamin B2 deficiency
✪✪✪✪✪

Nutritional vitamin B2 deficiency is rare and clinical signs are non-specific. One may find skin or mucous membrane lesions (seborrheic dermatitis, angular cheilosis, stomatitis with a "purple tongue") and sometimes ocular involvement with photophobia due to corneal and retinal lesions, conjunctival hypervascularization, growth retardation, anemia, kidney lesions, and degenerative changes of the nervous system. Vitamin B2 deficiency can occur in overall deficiencies such as unbalanced, protein-deficient diets, or through the use of unsupplemented infant formulas. nnIn ariboflavinosis, riboflavin has been used at doses of 5 to 30 mg per day in divided doses.nn

Posologie

posologieOral route

posologie5 - 30 mg

duration1 - years

populationAdults


Eye health
✪✪✪✪✪

Riboflavin plays a role in vision because it contributes to the formation of photoreceptors and provides structural protection to the eyes. FAD (a derivative of vitamin B2) is a cofactor for glutathione reductase activity. The increase in glutathione levels produced by this enzyme may play a role in the prevention of cataracts. Glutathione reductase reduces oxidized glutathione to its reduced form, GSH. GSH is thought to protect the lens against oxidative damage. Thus, affected patients appear to have low levels of GSH.

Posologie

posologieOral

posologie1.6 mg


Oxidative stress
✪✪✪✪✪

Riboflavin is an essential vitamin used to produce the two flavocoenzymes, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These coenzymes are mainly involved in oxidation-reduction reactions in the body. FAD plays an important role in the body's antioxidant system by serving as a cofactor for glutathione reductase (an enzyme that regenerates glutathione, a molecule essential for resistance to oxidative stress and for preserving intracellular pH).

Posologie

posologieOral

posologie1.6 mg


Hyperhomocysteinemia
✪✪✪✪

Homocysteine appears to be reduced by riboflavin supplementation, but this effect has only been observed in subjects carrying a specific genetic mutation (TT genotype) that reduces the activity of the methylenetetrahydrofolate reductase (MTHFR) enzyme involved in the remethylation of homocysteine to methionine. Indeed, taking 1.6 mg of riboflavin per day for 12 weeks increases riboflavin levels and reduces homocysteine levels by 22% to 40% in individuals with the TT genotype. On the other hand, taking 75 mg of riboflavin per day, in combination with folic acid at 0.4 mg and pyridoxine at 120 mg, in people with hyperhomocysteinemia caused by the use of antiepileptic drugs, reduces plasma total homocysteine by 26% compared with baseline.

Posologie

posologieOral

posologie1.6 - 75 mg

duration12 - weeks

populationAdults


Migraine
✪✪✪✪✪

In most clinical studies evaluating riboflavin supplementation, migraine prophylaxis in adults with migraine shows that taking 400 mg daily for up to 3 months can reduce the frequency, severity and duration of migraine attacks compared with placebo. In children with migraine, a daily dose of 200 mg for 4 weeks does not significantly improve migraine frequency. The effect of 400 mg of riboflavin per day in children with migraine has not been studied.

Posologie

posologieOral

posologie200 - 400 mg

duration3 - months

populationAdults


Cataract
✪✪✪✪✪

The daily intake of 3 mg riboflavin and 40 mg niacin in combination for 5 to 6 years appears to be associated with a lower risk of developing nuclear cataract compared with placebo.

Posologie

posologieOral

posologie3 - 40 mg

duration6 - years

populationAdults, Seniors


High blood pressure
✪✪✪✪✪

Riboflavin appears to reduce blood pressure in individuals carrying a specific genetic mutation (TT genotype) that reduces the activity of the methylenetetrahydrofolate reductase (MTHFR) enzyme involved in the remethylation of homocysteine to methionine. Indeed, preliminary clinical research suggests that taking 1.6 mg of riboflavin per day for 16 weeks reduces systolic blood pressure by 9 mmHg and diastolic blood pressure by 6 mmHg compared with placebo in individuals with the TT genotype and early cardiovascular disease.

Posologie

posologieOral

posologie1.6 mg

duration16 - weeks

populationAdults


Acid-Base Balance
✪✪✪✪✪

There is preliminary clinical evidence that riboflavin may be useful for treating lactic acidosis caused by treatment with a nucleoside analogue reverse transcriptase inhibitor (NRTI) in patients with human immunodeficiency virus (HIV). The mechanism is unclear.

Posologie

posologieOral

posologie1.6 mg


Sports Performance
✪✪✪✪✪

Riboflavin contributes to normal energy metabolism, the maintenance of normal red blood cells, and normal iron metabolism, which suggests its importance for athletes. In human research, restriction of riboflavin intake led to a significant reduction in athletic (aerobic) performance, in the onset of lactate accumulation in the blood, and in oxygen consumption. However, the role of riboflavin deficiency in these performance effects is not clear.

Posologie

posologieOral administration

posologie1.6 mg


Anemia
✪✪✪✪✪

Riboflavin plays a role in erythropoiesis (red blood cell formation), improves iron absorption, and helps mobilize ferritin from tissues. In studies, riboflavin deficiency has been shown to interfere with iron utilization, but not its absorption, and the observed anemia was not due to a lack of iron but to impaired hemoglobin synthesis. More recent Chinese data show that insufficient riboflavin intake is associated with an increased risk of persistent anemia. There was a positive association between riboflavin intake and anemia in women, particularly those under 50 years of age. Therefore, correcting a riboflavin deficiency may be one component of anemia prevention. Further trials are needed for this purpose.

Posologie

posologieOral administration

posologie10 mg


Cancer
✪✪✪✪✪

Studies suggest that riboflavin (vitamin B2) may play a protective role against certain cancers. An association has been observed between high levels of riboflavin in the blood and a reduced risk of precancerous lesions in the colon, as well as oral and pharyngeal cancers. In addition, a treatment combining riboflavin, coenzyme Q10, and niacin has shown a reduction in markers of breast cancer, suggesting potential to decrease the risk of cancer recurrence. nnThese findings open interesting perspectives on the role of riboflavin in cancer prevention.nn

Posologie

posologieOrally

posologie10 mg


Properties


Essential

full-leaffull-leaffull-leaffull-leaf

Riboflavin is an essential vitamin used in the production of the two flavocoenzymes, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) which are involved in energy production and nutrient utilization. These enzymes protect cells from aggressive (oxidizing) substances produced during the chemical reactions of metabolism. Small amounts of riboflavin are present in most animal and plant tissues. Riboflavin is found in many foods, including milk, meat, eggs, nuts, enriched flour, and green vegetables. Riboflavin deficiency is very rare in Western countries. Insufficient intake manifests, for example, as cracks on the lips and at the corners of the mouth, oily skin, or sore throat. It is more commonly observed in alcoholics, or in those who have a very unbalanced diet.

Usages associés

Vitamin B2 deficiency, Anemia

Antioxidant

full-leaffull-leaffull-leaffull-leaf

Riboflavin is an essential vitamin used to produce the two flavocoenzymes, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These coenzymes are primarily involved in redox reactions in the body. FAD plays an important role in the body's antioxidant system, acting as a cofactor for glutathione reductase (an enzyme that helps regenerate glutathione, a molecule essential for resistance to oxidative stress and for maintaining intracellular pH).

Usages associés

Oxidative stress

Vision

full-leaffull-leaffull-leafempty-leaf

Riboflavin plays a role in vision because it contributes to the formation of photoreceptors and structurally protects the eyes. FAD (a derivative of vitamin B2) is a cofactor for glutathione reductase activity. The increase in glutathione levels produced by this enzyme may play a role in preventing cataracts. Glutathione reductase reduces oxidized glutathione to its reduced form, GSH. GSH is thought to protect the lens against oxidative damage. Thus, affected patients appear to have low levels of GSH.

Usages associés

Cataract, Eye health

Neurological

full-leaffull-leaffull-leafempty-leaf

Riboflavin is necessary for the metabolism of essential fatty acids. In addition, riboflavin is involved in the formation of myelin in both the central nervous system and the peripheral nervous system. In patients deficient in riboflavin, nerve components, including lipids, are reduced, which may affect brain development. On the other hand, decreased riboflavin levels appear to play a role in the pathophysiology of migraine. Indeed, in migraine there is mitochondrial dysfunction, and riboflavin is necessary for normal mitochondrial function. Thus, it is assumed that riboflavin supplementation may reduce pain or possibly prevent migraines.

Usages associés

Migraine

Anticancer

full-leaffull-leaffull-leafempty-leaf

In epidemiological research, plasma riboflavin has been inversely associated with the risk of advanced colorectal adenoma lesions. Riboflavin has also been shown to be inversely associated with the risk of oral and pharyngeal cancer. However, in a separate study, dietary intakes of B vitamins, including riboflavin, were not associated with the risk of breast, endometrial, ovarian, colorectal, lung, or thyroid cancer. In human research, a treatment regimen containing riboflavin, coenzyme Q10, and niacin reduced breast cancer tumor markers — carcinoembryonic antigen and carbohydrate antigen — reduced angiogenesis markers and cytokines, increased poly(ADP-ribose) polymerase levels, and resulted in disappearance of methylation patterns of the RASSF1A gene. RASSF1A is a tumor suppressor gene whose role is to modulate the cell cycle and apoptosis. It is often inactivated by promoter hypermethylation in various types of cancer. This could indicate a reduced risk of cancer recurrence and metastasis. However, the effect of riboflavin alone is unclear.

Usages associés

Cancer

Cardiovascular

full-leaffull-leafempty-leafempty-leaf

Flavin adenine dinucleotide (FAD), a derivative of riboflavin, is a cofactor of the enzyme methylenetetrahydrofolate reductase (MTHFR) involved in the remethylation of homocysteine to methionine (homocysteine is known as a risk factor for cardiovascular disease). nnIn patients carrying a specific gene mutation that reduces MTHFR enzyme activity, MTHFR levels are decreased (due to reduced binding of the MTHFR enzyme to its riboflavin cofactor (FAD)). This leads to increased plasma homocysteine levels. Riboflavin supplementation is thought to decrease homocysteine levels and may restore MTHFR concentrations.nn

Usages associés

Hyperhomocysteinemia, Hypertension


Safe dosage

Adults 18 years and older: 1.6 mg

Infants up to 12 months: 0.4 mg

Children 1 to 3 years: 0.6 mg

Children 4 to 6 years: 0.7 mg

Children 7 to 10 years: 1 mg

Children 11 to 14 years: 1.4 mg

Children 15 to 17 years: 1.6 mg

Lactating women 18 years and older: 2 mg

Pregnant women 18 years and older: 1.9 mg


Interactions

Médicaments

Tetracyclines: moderate interaction

Riboflavin may reduce the effect of tetracycline antibiotics.

Plantes ou autres actifs

Vitamin B2: moderate interaction

Riboflavin supplements can improve the hematologic response to iron supplements in some people with anemia. Riboflavin is thought to be involved in mobilizing iron from ferritin (the iron-storage protein) for the synthesis of heme and globin, but it does not appear to significantly affect iron absorption. The effect of riboflavin on iron utilization is likely only significant in people who are riboflavin-deficient.